Bio-TechneMEX:TECH 83 OCF Margin % is 27.83% as of Mar. 2026, which is 6% above its 10-year median of 26.15. GuruFocus rates MEX:TECH with a GF Score™ of 83/100 and a GF Value™ of MXN1,117.60. The stock has 8 warning signs investors should review. Among 959 Biotechnology companies, Bio-Techne ranks better than 86.76% on this metric.
The historical rank and industry rank for Bio-Techne's OCF Margin % or its related term are showing as below:
MEX:TECH'
s OCF Margin % Range Over the Past 10 Years
Min: 22.38 Med: 26.15 Max: 37.83
Current: 24.35
During the past 13 years, the highest OCF Margin % of Bio-Techne was 37.83%. The lowest was 22.38%. And the median was 26.15%.
MEX:TECH's OCF Margin % is ranked better than 86.76% of 959
companies
in the Biotechnology industry
Industry Median: -66.52
vs MEX:TECH: 24.35
Bio-Techne OCF Margin % Related Terms
Bio-Techne OCF Margin % Historical Data
* Premium members only.
The historical data trend for Bio-Techne's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:TECH vs HALO, IBRX, NUVL: OCF Margin % Comparison
For the Biotechnology subindustry, Bio-Techne's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bio-Techne OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Bio-Techne's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Bio-Techne's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bio-Techne (MEX:TECH) has a OCF Margin % of 27.83% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bio-Techne and its competitors. This is near median its historical median of 26.15. Over the past decade, Bio-Techne's OCF Margin % has ranged from 22.38 to 37.83. According to the industry distribution chart, Bio-Techne ranks #127 out of 959 companies in the Biotechnology industry, placing it in the top 13.2%.
Is Bio-Techne's OCF Margin % too high?
Bio-Techne's current OCF Margin % of 27.83% is near median its 10-year median of 26.15. Over the past 10 years, this metric has ranged from a low of 22.38 to a high of 37.83. Based on the distribution chart, Bio-Techne ranks #127 out of 959 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Bio-Techne has a GF Score™ of 83/100, reflecting its overall financial health beyond just this single metric.
How does Bio-Techne's OCF Margin % compare to HALO and IBRX?
According to the Biotechnology industry distribution chart, Bio-Techne ranks #127 out of 959 companies for OCF Margin %. This places Bio-Techne in the top 13% of its industry — outperforming the majority of peers. Historically, Bio-Techne's own OCF Margin % has ranged from 22.38 to 37.83 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Bio-Techne and its competitors. Bio-Techne's current OCF Margin % is 27.83%, which is near median its own 10-year median of 26.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bio-Techne stock overvalued right now?
Bio-Techne (MEX:TECH) has a current OCF Margin % of 27.83%. The stock's GF Value™ is MXN1,117.60, compared to a current price of MXN1,090.00 — trading 2.5% below its estimated fair value. The current OCF Margin % is 27.83%, which is near median its 10-year median of 26.15. Bio-Techne's overall GF Score™ is 83/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Bio-Techne (MEX:TECH), the current OCF Margin % is 27.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bio-Techne (MEX:TECH) Overvalued in 2026?
Based on GuruFocus' analysis, Bio-Techne stock appears to be undervalued.
The current stock price of MXN1,090.00 is trading 2.5% below its estimated GF Value™ of MXN1,117.60.
Key valuation signals for MEX:TECH:
OCF Margin %: 27.83% (near median its 10-year median of 26.15)
GF Value™: MXN1,117.60 vs. price of MXN1,090.00 (2.5% below fair value)
No single metric tells the full story. See the MEX:TECH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
83GF Score
Get the complete analysis for MEX:TECH
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:TECH has been successfully added to your 
